Displaying items 15841-15860 of 48586 in total

Riding the Rocket: SpaceX Goes 2X, But at What Cost to Investors?

Read full article
Riding the Rocket: SpaceX Goes 2X, But at What Cost to Investors?

The Electrification Mandate: Global Business Demands a Post-Fossil Fuel World

Read full article
BriefGlance

Reputation is the New Rubble: How Digital Trust Rebuilt an Old Industry

Read full article
Reputation is the New Rubble: How Digital Trust Rebuilt an Old Industry

Macau Sporting Club's Digital Gambit: Beyond the World Cup Hype

Read full article
Macau Sporting Club's Digital Gambit: Beyond the World Cup Hype

From Payder Lender to Tech Titan: Wonga SA's Responsible Revolution

Read full article
From Payder Lender to Tech Titan: Wonga SA's Responsible Revolution

CnerG Buys Monsoon Carbon, Marrying Tech with On-the-Ground Sourcing

Read full article
CnerG Buys Monsoon Carbon, Marrying Tech with On-the-Ground Sourcing

Philippines Eyes Solar Leap with Chinese Giant's 'Zero Cost' Entry

Read full article
Philippines Eyes Solar Leap with Chinese Giant's 'Zero Cost' Entry

ComEd’s Restoration Feat and the $15.3 Billion Question It Poses

Read full article
ComEd’s Restoration Feat and the $15.3 Billion Question It Poses

The Green Gold Rush: Jereh’s Blueprint for a Global Recycling Ecosystem

Read full article
The Green Gold Rush: Jereh’s Blueprint for a Global Recycling Ecosystem

Marketing’s AI Mirage: Belief Is High, But True Transformation Is Lagging

Read full article
Marketing’s AI Mirage: Belief Is High, But True Transformation Is Lagging

Korea’s AI Race: A $50M Alliance to Bridge the Critical Compute Gap

Read full article
BriefGlance

TOM 50 RE: AeroVironment's Bid to Dominate the Tactical Ground Game

Read full article
TOM 50 RE: AeroVironment's Bid to Dominate the Tactical Ground Game

OM Pharma’s Data Gambit: How Real-World Evidence Transforms a Legacy Drug

Read full article
OM Pharma’s Data Gambit: How Real-World Evidence Transforms a Legacy Drug

Genmab's Epcoritamab Shatters Expectations for Elderly Lymphoma Patients

Read full article
Genmab's Epcoritamab Shatters Expectations for Elderly Lymphoma Patients

Hisense's World Cup Gambit: Tech, Turf, and the Battle for Your Living Room

Read full article
Hisense's World Cup Gambit: Tech, Turf, and the Battle for Your Living Room

Solar's New Frontier: GCL SI's Precision Tech for Extreme Environments

Read full article
Solar's New Frontier: GCL SI's Precision Tech for Extreme Environments

The Digital Scaffolding of Southeast Asia's EV Revolution

Read full article
BriefGlance

HashKey's HKD100M Buyback: A Bold Bet on Web3's Future Amid Market Lows

Read full article
HashKey's HKD100M Buyback: A Bold Bet on Web3's Future Amid Market Lows

Beyond Opioids: Lateral Pharma Unveils a New Target in the War on Pain

Read full article
Beyond Opioids: Lateral Pharma Unveils a New Target in the War on Pain

The Hamanasi Signal: How a Belizean Resort Redefined Global Luxury

Read full article
The Hamanasi Signal: How a Belizean Resort Redefined Global Luxury